Unit: School of Medicine
Department: Department of Medicine, Hematology and Oncology
Office location and address
1335 Lee StCharlottesville, Virginia 22903
MD-INMD-HO A Phase 3 Open Label Extension Study of Fostamatinib Disodium in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura
Source: Rigel Pharmaceuticals, Inc.
September 04, 2014 – November 30, 2016